Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-21
DOI
10.3389/fendo.2020.00070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2019) Yoshimasa Aso et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Treatment options for nonalcoholic fatty liver disease
- (2019) Amir Anushiravani et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
- (2019) Mary E. Rinella et al. HEPATOLOGY
- Rates and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
- (2018) Ma Ai Thanda Han et al. Clinical Gastroenterology and Hepatology
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Effects of liraglutide, metformin, and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial
- (2018) Wen-Huan Feng et al. Journal of Diabetes Investigation
- Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study
- (2018) Niina Matikainen et al. DIABETES OBESITY & METABOLISM
- Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease
- (2018) Gabriela Handzlik-Orlik et al. Pharmacological Reports
- Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- (2018) Francesco Bifari et al. PHARMACOLOGICAL RESEARCH
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Metformin for Rapidly Maturing Girls with Central Adiposity: Less Liver Fat and Slower Bone Maturation
- (2017) Francis de Zegher et al. Hormone Research in Paediatrics
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
- (2016) A. Dutour et al. DIABETES OBESITY & METABOLISM
- Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
- (2016) Mark M. Smits et al. DIABETOLOGIA
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study
- (2016) Jean-Michel Petit et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Effect of Insulin Versus Triple Oral Therapy on the Progression of Hepatic Steatosis in Type 2 Diabetes
- (2016) Ildiko Lingvay et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
- (2015) An Tang et al. DIABETES CARE
- Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease
- (2015) Elena Sofer et al. Hepatology International
- Does Metformin Treatment Influence Bone Formation in Patients with Nonalcoholic Fatty Liver Disease?
- (2015) E. Soifer et al. HORMONE AND METABOLIC RESEARCH
- Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes
- (2014) Yan Bi et al. ACTA DIABETOLOGICA
- Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease
- (2014) Hui Fan et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes
- (2014) Ning Shao et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus
- (2013) Daisuke Suzuki et al. INTERNAL MEDICINE
- Metformin in Obese Children and Adolescents: The MOCA Trial
- (2012) D. Kendall et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial
- (2011) S. L. Samson et al. DIABETOLOGIA
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome
- (2011) Mira Aubuchon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
- (2011) Elena Sofer et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Combined Exenatide and Pioglitazone Therapy on Hepatic Fat Content in Type 2 Diabetes
- (2011) Padma Sathyanarayana et al. Obesity
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
- (2010) G A Garinis et al. INTERNATIONAL JOURNAL OF OBESITY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Metformin and Weight Loss on Serum Alanine Aminotransferase Activity in the Diabetes Prevention Program
- (2010) Jonathan Krakoff et al. Obesity
- Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
- (2009) Ziya Omer et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Comparative Study of Low-dose Pioglitazone or Metformin Treatment in Japanese Diabetic Patients with Metabolic Syndrome
- (2009) T. Kato et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): A randomized controlled pilot trial
- (2009) N. Sturm et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
- (2009) Alok K. Gupta et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
- (2008) A. Nar et al. ACTA DIABETOLOGICA
- Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
- (2008) R. IDILMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Improvement of Physical Health and Quality of Life of Alcohol-Dependent Individuals With Topiramate TreatmentUS Multisite Randomized Controlled Trial
- (2008) Bankole A. Johnson ARCHIVES OF INTERNAL MEDICINE
- Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study
- (2008) V NOBILI et al. CLINICAL THERAPEUTICS
- Why Most Discovered True Associations Are Inflated
- (2008) John P. A. Ioannidis EPIDEMIOLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
- The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome
- (2008) D. Preiss et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents
- (2008) Kristen J Nadeau et al. PEDIATRIC DIABETES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now